对多个抗原表位的计算预测
Rajalakshmi Viswanathan1, Moshe Carroll1, Alexandra Roffe2
1Department of Chemistry and Biochemistry, Yeshiva College, New York, NY 10033, United States.
Bioinformatics (Oxford, England)
|September 13, 2024
概括
我们开发了ISPIPab,这是一种用于预测抗原表位的新型计算工具,提高了疫苗设计和诊断的准确性. 这种方法结合了多种方法,以有效地识别已知的和新的表征.
科学领域:
- 免疫信息学是指免疫信息学.
- 计算生物学 计算生物学
- 生物技术是生物技术.
背景情况:
- 准确的抗原表位标识对于疫苗设计,诊断和药物开发至关重要.
- 实验性表位确定是劳动密集型和昂贵的,需要计算解决方案.
- 现有的计算表位预测工具在准确性和适用性方面存在局限性.
研究的目的:
- 开发一种改进的计算方法来预测抗原表位.
- 为了提高表位预测的准确性和范围,超越当前最先进的方法.
主要方法:
- 介绍了ISPIPab,这是一个新的抗原表位预测程序.
- 在ISPIPab.中集成两个基于特征的方法和一个基于对接的方法.
- 与预测算法一起应用等级集群的应用.
主要成果:
- 与单个组成方法相比,ISPIPab表现出优越的性能.
- ISPIPab的表现优于其他最先进的表位预测工具.
- 综合方法成功地确定了已知的表位,并揭示了新的潜在目标.
结论:
- ISPIPab在计算表位预测方面取得了重大进展.
- 该工具有助于识别既定和新的表征,以便进一步研究.
- 这种方法增强了医学应用,如疫苗开发和免疫诊断.
更多相关视频
相关概念视频
Cross-reactivity
31.0K
Overview
31.0K
Antigens Involved in Adaptive Immunity
474
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
474
Diversity of Antigen Receptors
541
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
541
Hybridoma Technology
14.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K


